Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.


Journal

Journal of patient-reported outcomes
ISSN: 2509-8020
Titre abrégé: J Patient Rep Outcomes
Pays: Germany
ID NLM: 101722688

Informations de publication

Date de publication:
09 Jul 2024
Historique:
accepted: 13 02 2024
medline: 9 7 2024
pubmed: 9 7 2024
entrez: 8 7 2024
Statut: epublish

Résumé

Although comprehensive and widespread guidelines on how to conduct systematic reviews of outcome measurement instruments (OMIs) exist, for example from the COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) initiative, key information is often missing in published reports. This article describes the development of an extension of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guideline: PRISMA-COSMIN for OMIs 2024. The development process followed the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) guidelines and included a literature search, expert consultations, a Delphi study, a hybrid workgroup meeting, pilot testing, and an end-of-project meeting, with integrated patient/public involvement. From the literature and expert consultation, 49 potentially relevant reporting items were identified. Round 1 of the Delphi study was completed by 103 panelists, whereas round 2 and 3 were completed by 78 panelists. After 3 rounds, agreement (≥67%) on inclusion and wording was reached for 44 items. Eleven items without consensus for inclusion and/or wording were discussed at a workgroup meeting attended by 24 participants. Agreement was reached for the inclusion and wording of 10 items, and the deletion of 1 item. Pilot testing with 65 authors of OMI systematic reviews further improved the guideline through minor changes in wording and structure, finalized during the end-of-project meeting. The final checklist to facilitate the reporting of full systematic review reports contains 54 (sub)items addressing the review's title, abstract, plain language summary, open science, introduction, methods, results, and discussion. Thirteen items pertaining to the title and abstract are also included in a separate abstract checklist, guiding authors in reporting for example conference abstracts. PRISMA-COSMIN for OMIs 2024 consists of two checklists (full reports; abstracts), their corresponding explanation and elaboration documents detailing the rationale and examples for each item, and a data flow diagram. PRISMA-COSMIN for OMIs 2024 can improve the reporting of systematic reviews of OMIs, fostering their reproducibility and allowing end-users to appraise the quality of OMIs and select the most appropriate OMI for a specific application. NOTE: In order to encourage its wide dissemination this article is freely accessible on the web sites of the journals: Health and Quality of Life Outcomes; Journal of Clinical Epidemiology; Journal of Patient-Reported Outcomes; Quality of Life Research.

Identifiants

pubmed: 38977535
doi: 10.1186/s41687-024-00727-7
pii: 10.1186/s41687-024-00727-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

64

Subventions

Organisme : CIHR
ID : 452145
Pays : Canada

Informations de copyright

© 2024. The Author(s).

Références

Butcher NJ, Monsour A, Mew EJ, Chan A-W, Moher D, Mayo-Wilson E, Terwee CB, Chee-A-Tow A, Baba A, Gavin F (2022) Guidelines for reporting outcomes in trial reports: the CONSORT-outcomes 2022 extension. JAMA 328(22):2252–2264
pubmed: 36511921 doi: 10.1001/jama.2022.21022
Prinsen CA, Mokkink LB, Bouter LM, Alonso J, Patrick DL, De Vet HC, Terwee CB (2018) COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res 27(5):1147–1157
pubmed: 29435801 pmcid: 5891568 doi: 10.1007/s11136-018-1798-3
Porter ME (2010) What is value in health care. N Engl J Med 363(26):2477–2481
pubmed: 21142528 doi: 10.1056/NEJMp1011024
Nelson EC, Eftimovska E, Lind C, Hager A, Wasson JH, Lindblad S (2015) Patient reported outcome measures in practice. BMJ. https://doi.org/10.1136/bmj.g7818
doi: 10.1136/bmj.g7818 pubmed: 26578347 pmcid: 4647185
OMERACT (2021) The OMERACT handbook for establishing and implementing core outcomes in clinical trials across the spectrum of rheumatologic conditions. OMERACT
Stephenson M, Riitano D, Wilson S, Leonardi-Bee J, Mabire C, Cooper K, Monteiro da Cruz D, Moreno-Casbas M, Lapkin S (2020) Chapter 12: systematic reviews of measurement properties. In: Aromataris E, Munn Z (eds) JBI Manual for Evidence Synthesis. JBI
Mokkink LB, Terwee CB, Stratford PW, Alonso J, Patrick DL, Riphagen I, Knol DL, Bouter LM, de Vet HC (2009) Evaluation of the methodological quality of systematic reviews of health status measurement instruments. Qual Life Res 18(3):313–333
pubmed: 19238586 doi: 10.1007/s11136-009-9451-9
Terwee CB, Prinsen C, Garotti MR, Suman A, De Vet H, Mokkink LB (2016) The quality of systematic reviews of health-related outcome measurement instruments. Qual Life Res 25(4):767–779
pubmed: 26346986 doi: 10.1007/s11136-015-1122-4
Lorente S, Viladrich C, Vives J, Losilla J-M (2020) Tools to assess the measurement properties of quality of life instruments: a meta-review. BMJ Open 10(8):e036038
McKenna SP, Heaney A (2021) Setting and maintaining standards for patient-reported outcome measures: can we rely on the COSMIN checklists? J Med Econ 24(1):502–511
pubmed: 33759686 doi: 10.1080/13696998.2021.1907092
Altman DG, Simera I (2014) Using reporting guidelines effectively to ensure good reporting of health research. Guidelines for reporting health research: a user’s manual, vol 25. pp 32–40
Moher D, Schulz KF, Simera I, Altman DG (2010) Guidance for developers of health research reporting guidelines. PLoS Med 7(2):e1000217
pubmed: 20169112 pmcid: 2821895 doi: 10.1371/journal.pmed.1000217
Jin Y, Sanger N, Shams I, Luo C, Shahid H, Li G, Bhatt M, Zielinski L, Bantoto B, Wang M (2018) Does the medical literature remain inadequately described despite having reporting guidelines for 21 years? A systematic review of reviews: an update. J Multidiscip Healthc 27:495–510
doi: 10.2147/JMDH.S155103
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group* T (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269
pubmed: 19622511 doi: 10.7326/0003-4819-151-4-200908180-00135
Panic N, Leoncini E, de Belvis G, Ricciardi W, Boccia S (2013) Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses. PLoS ONE 8(12):e83138
pubmed: 24386151 pmcid: 3873291 doi: 10.1371/journal.pone.0083138
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 88:105906
pubmed: 33789826 doi: 10.1016/j.ijsu.2021.105906
COSMIN (2023) Guideline for systematic reviews of outcome measurement instruments. Available via https://www.cosmin.nl/tools/guideline-conducting-systematic-review-outcome-measures/ . Accessed Apr 2023
Butcher NJ, Monsour A, Mokkink LB, Terwee CB, Tricco AC, Gagnier J, Offringa M (2021) Needed: guidance for reporting knowledge synthesis studies on measurement properties of outcome measurement instruments in health research
Elsman EB, Smith M, Hofstetter C, Gavin F, Jobson E, Markham S, Ricketts J, Baba A, Butcher NJ, Offringa M (2024) A blueprint for patient and public involvement in the development of a reporting guideline for systematic reviews of outcome measurement instruments: PRISMA-COSMIN for OMIs 2024. Res Involv Engagem 10(33). https://doi.org/10.1186/s40900-024-00563-5
Staniszewska S, Brett J, Simera I, Seers K, Mockford C, Goodlad S, Altman D, Moher D, Barber R, Denegri S (2017) GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research. BMJ. https://doi.org/10.1136/bmj.j3453
doi: 10.1136/bmj.j3453 pubmed: 28768629 pmcid: 5539518
EQUATOR (2023) PRISMA-COSMIN? Recommendations for reporting systematic reviews of outcome measurement instruments. Available via https://www.equator-network.org/library/reporting-guidelines-under-development/reporting-guidelines-under-development-for-systematic-reviews/#PRISMACOSMIN . Accessed 14 Sept 2023
Elsman EB, Baba A, Butcher NJ, Offringa M, Moher D, Terwee CB, Mokkink LB, Smith M, Tricco, A (2023) PRISMA-COSMIN. OSF
Elsman EB, Butcher NJ, Mokkink LB, Terwee CB, Tricco A, Gagnier JJ, Aiyegbusi OL, Barnett C, Smith M, Moher D (2022) Study protocol for developing, piloting and disseminating the PRISMA-COSMIN guideline: a new reporting guideline for systematic reviews of outcome measurement instruments. Syst Rev 11(1):121
pubmed: 35698213 pmcid: 9195229 doi: 10.1186/s13643-022-01994-5
Terwee CB, Prinsen CA, Chiarotto A, Westerman MJ, Patrick DL, Alonso J, Bouter LM, De Vet HC, Mokkink LB (2018) COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a delphi study. Qual Life Res 27(5):1159–1170
pubmed: 29550964 pmcid: 5891557 doi: 10.1007/s11136-018-1829-0
Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, Bouter LM, de Vet HC (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60(1):34–42
pubmed: 17161752 doi: 10.1016/j.jclinepi.2006.03.012
Prinsen CA, Vohra S, Rose MR, Boers M, Tugwell P, Clarke M, Williamson PR, Terwee CB (2016) How to select outcome measurement instruments for outcomes included in a “Core Outcome Set”–a practical guideline. Trials 17(1):1–10
doi: 10.1186/s13063-016-1555-2
Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Trials 11(1):1–8
doi: 10.1186/1745-6215-11-32
Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ 85:867–872
doi: 10.2471/BLT.07.045120
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Lijmer JG, Moher D, Rennie D, De Vet HC (2015) STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Clin Chem 61(12):1446–1452
pubmed: 26510957 doi: 10.1373/clinchem.2015.246280
Kottner J, Audige L, Brorson S, Donner A, Gajewski BJ, Hrobjartsson A, Roberts C, Shoukri M, Streiner DL (2011) Guidelines for reporting reliability and agreement studies (GRRAS) were proposed. Int J Nurs Stud 48(6):661–671
pubmed: 21514934 doi: 10.1016/j.ijnurstu.2011.01.016
Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA (2013) SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 158(3):200–207
pubmed: 23295957 pmcid: 5114123 doi: 10.7326/0003-4819-158-3-201302050-00583
FDA (2009) Guidance for Industry - Patient-Reported Outcome Measures: use in Medical Product Development to Support Labeling Claims. U.S. Department of Health and Human Services Food and Drug Administration
Revicki DA, Erickson PA, Sloan JA, Dueck A, Guess H, Santanello NC, Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group (2007) Interpreting and reporting results based on patient-reported outcomes. Value Health 10:S116–S124
pubmed: 17995470 doi: 10.1111/j.1524-4733.2007.00274.x
Staquet M, Berzon R, Osoba D, Machin D (1996) Guidelines for reporting results of quality of life assessments in clinical trials. Qual Life Res 5(5):496–502
pubmed: 8973129 doi: 10.1007/BF00540022
AHRQ (2019) Methods guide for effectiveness and comparative effectiveness reviews. Agency for Healthcare Research and Quality
Aromataris E, Munn Z (2020) JBI Manual for evidence synthesis. JBI
Brundage M, Blazeby J, Revicki D, Bass B, De Vet H, Duffy H, Efficace F, King M, Lam CL, Moher D (2013) Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards. Qual Life Res 22(6):1161–1175
pubmed: 22987144 doi: 10.1007/s11136-012-0252-1
Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD, CONSORT PRO Group (2013). Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA 309(8):814–822
pubmed: 23443445 doi: 10.1001/jama.2013.879
CRD (2009) CRD’s guidance for undertaking reviews in health care. Centre for Reviews and Dissemination
Gagnier JJ, Lai J, Mokkink LB, Terwee CB (2021) COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures. Qual Life Res 30:1–22
doi: 10.1007/s11136-021-02822-4
Higgins J, Lasserson T, Chandles J, Tovey D, Flemyng E, Churchill R (2021) Methodological expectations of cochrane intervention reviews. Cochrane
Lohr KN (2002) Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 11(3):193–205
pubmed: 12074258 doi: 10.1023/A:1015291021312
McInnes MD, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Clifford T, Cohen JF, Deeks JJ, Gatsonis C, Hooft L (2018) Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA 319(4):388–396
pubmed: 29362800 doi: 10.1001/jama.2017.19163
Mokkink LB, De Vet HC, Prinsen CA, Patrick DL, Alonso J, Bouter LM, Terwee CB (2018) COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res 27(5):1171–1179
pubmed: 29260445 doi: 10.1007/s11136-017-1765-4
Morton S, Berg A, Levit L, Eden J (2011) Standards for reporting systematic reviews. Finding what works in health care standards for systematic reviews. Institute of Medicine
NQF (2011) Guidance for measure testing and evaluating scientific acceptability of measure properties. National Quality Forum
PCORI (2021) Draft final research report: instructions for awardee. Patient-Centered Outcomes Research Institute
Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB, Snyder CF, Schwartz C, Revicki DA, Moinpour CM, McLeod LD (2013) ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res 22(8):1889–1905
pubmed: 23288613 doi: 10.1007/s11136-012-0344-y
Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. https://doi.org/10.1136/bmj.g7647
doi: 10.1136/bmj.g7647 pubmed: 25976398
Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, Tierney JF (2015) Preferred reporting items for a systematic review and meta-analysis of individual participant data: the PRISMA-IPD statement. JAMA 313(16):1657–1665
pubmed: 25919529 doi: 10.1001/jama.2015.3656
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MD, Horsley T, Weeks L (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169(7):467–473
pubmed: 30178033 doi: 10.7326/M18-0850
Elsman EB, Mokkink LB, Langendoen-Gort M, Rutters F, Beulens J, Elders PJ, Terwee CB (2022) Systematic review on the measurement properties of diabetes-specific patient-reported outcome measures (PROMs) for measuring physical functioning in people with type 2 diabetes. BMJ Open Diabetes Res Care 10(3):e002729
pubmed: 35675952 pmcid: 9185403 doi: 10.1136/bmjdrc-2021-002729
Abma IL, Butje BJ, Peter M, van der Wees PJ (2021) Measurement properties of the dutch-flemish patient-reported outcomes measurement information system (PROMIS) physical function item bank and instruments: a systematic review. Health Qual Life Outcomes 19(1):1–22
doi: 10.1186/s12955-020-01647-y
Mehdipour A, Wiley E, Richardson J, Beauchamp M, Kuspinar A (2021) The performance of digital monitoring devices for oxygen saturation and respiratory rate in COPD: a systematic review. COPD 18(4):469–475
pubmed: 34223780 doi: 10.1080/15412555.2021.1945021
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381
pubmed: 18929686 doi: 10.1016/j.jbi.2008.08.010
Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, Bouter LM, De Vet HC (2010) The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international delphi study. Qual Life Res 19(4):539–549
pubmed: 20169472 pmcid: 2852520 doi: 10.1007/s11136-010-9606-8
Mokkink LB, Boers M, van der Vleuten C, Bouter LM, Alonso J, Patrick DL, De Vet HC, Terwee CB (2020) COSMIN Risk of Bias tool to assess the quality of studies on reliability or measurement error of outcome measurement instruments: a delphi study. BMC Med Res Methodol 20(1):1–13
doi: 10.1186/s12874-020-01179-5
Butcher NJ, Monsour A, Mew EJ, Chan A-W, Moher D, Mayo-Wilson E, Terwee CB, Chee-A-Tow A, Baba A, Gavin F (2022) Guidelines for reporting outcomes in trial protocols: the SPIRIT-outcomes 2022 extension. JAMA 328(23):2345–2356
pubmed: 36512367 doi: 10.1001/jama.2022.21243
COSMIN. COSMIN database of systematic reviews. Available via www.cosmin.nl/tools/database-systematic-reviews/ . Accessed 30 Jan 2022
Cochrane (2023) Cochrane consumer network: a network for patients and carers within Cochrane. Available via https://consumers.cochrane.org/healthcare-users-cochrane . Accessed 6 Apr 2023
COMET (2023) COMET POPPIE Working Group. Available via https://www.comet-initiative.org/Patients/POPPIE . Accessed 6 Apr 2023
OMERACT (2023) OMERACT Patient Research Partners. Available via https://omeractprpnetwork.org/ . Accessed 6 Apr 2023
SPOR (2023) Strategy for patient-oriented research. Available via https://sporevidencealliance.ca/ . Accessed 6 Apr 2023
Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, Bouter LM, de Vet HC (2010) The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 63(7):737–745
pubmed: 20494804 doi: 10.1016/j.jclinepi.2010.02.006
Gates M, Gates A, Pieper D, Fernandes RM, Tricco AC, Moher D, Brennan SE, Li T, Pollock M, Lunny C (2022) Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement. BMJ. https://doi.org/10.1136/bmj-2022-070849
doi: 10.1136/bmj-2022-070849 pubmed: 35944924 pmcid: 9361065
PROSPERO (2023) PROSPERO: international prospective register of systematic reviews. Centre for Reviews and Dissemination
Beller EM, Glasziou PP, Altman DG, Hopewell S, Bastian H, Chalmers I, Gotzsche PC, Lasserson T, Tovey D, PRISMA for Abstracts Group (2013) PRISMA for abstracts: reporting systematic reviews in journal and conference abstracts. PLoS Med 10(4):e1001419
pubmed: 23585737 pmcid: 3621753 doi: 10.1371/journal.pmed.1001419
Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE (2021) PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. https://doi.org/10.1136/bmj.n160
doi: 10.1136/bmj.n160 pubmed: 33782057 pmcid: 8479591
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (2022) Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane
Salameh J-P, Bossuyt PM, McGrath TA, Thombs BD, Hyde CJ, Macaskill P, Deeks JJ, Leeflang M, Korevaar DA, Whiting P (2020) Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist. BMJ. https://doi.org/10.1136/bmj.m2632
doi: 10.1136/bmj.m2632 pubmed: 32816740
Walton MK, Powers JH III, Hobart J, Patrick D, Marquis P, Vamvakas S, Isaac M, Molsen E, Cano S, Burke LB (2015) Clinical outcome assessments: conceptual foundation—report of the ISPOR clinical outcomes assessment–emerging good practices for outcomes research task force. Value Health 18(6):741–752
pubmed: 26409600 pmcid: 4610138 doi: 10.1016/j.jval.2015.08.006
Schünemann H, Brożek J, Guyatt G, Oxman A (2013) Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Updated October, 2013
Boutron I, Page M, Higgins J, Altman D, Lundh A, Hrobjartsson A, et al (2022) Chapter 7: considering bias and conflicts of interest among the included studies. Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane 2020. In Higgins J (ed) Cochrane handbook for systematic reviews of interventions version 6.3. Cochrane
Beaton DE, Maxwell LJ, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO, Conaghan PG, D’Agostino MA, De Wit MP (2019) Instrument selection using the OMERACT filter 21: the OMERACT methodology. J Rheumatol 46(8):1028–1035
pubmed: 30709952 doi: 10.3899/jrheum.181218
Lewis CC, Mettert KD, Stanick CF, Halko HM, Nolen EA, Powell BJ, Weiner BJ (2021) The psychometric and pragmatic evidence rating scale (PAPERS) for measure development and evaluation. Implement Res Pract 2:26334895211037390
pubmed: 37089994 pmcid: 9981887 doi: 10.1177/26334895211037391
Schlussel MM, Sharp MK, de Beyer JA, Kirtley S, Logullo P, Dhiman P, MacCarthy A, Koroleva A, Speich B, Bullock GS (2023) Reporting guidelines used varying methodology to develop recommendations. J Clin Epidemiol. https://doi.org/10.1016/j.jclinepi.2023.03.018
doi: 10.1016/j.jclinepi.2023.03.018 pubmed: 37898461
Kane M (2013) The argument-based approach to validation. Sch Psychol Rev 42(4):448–457
doi: 10.1080/02796015.2013.12087465
Weinfurt KP (2021) Constructing arguments for the interpretation and use of patient-reported outcome measures in research: an application of modern validity theory. Qual Life Res 30(6):1715–1722
pubmed: 33630235 doi: 10.1007/s11136-021-02776-7
AERA (2014) The standards for educational and psychological testing. The American Educational Research Association (AERA)
Zumbo B, Chan E (2014) Validity and validation in social, behavioral, and health sciences. In: Social indicators research series, vol 54. Springer International Publishing
doi: 10.1007/978-3-319-07794-9

Auteurs

Ellen B M Elsman (EBM)

Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada.
Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, Netherlands.

Lidwine B Mokkink (LB)

Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, Netherlands.

Caroline B Terwee (CB)

Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, Netherlands.

Dorcas Beaton (D)

Institute of Work and Health, Toronto, ON, Canada.

Joel J Gagnier (JJ)

Department of Epidemiology and Biostatistics and Department of Surgery, Western University, London, ON, Canada.

Andrea C Tricco (AC)

Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
Epidemiology Division and Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Queen's Collaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, Canada.

Ami Baba (A)

Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada.

Nancy J Butcher (NJ)

Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada.
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Maureen Smith (M)

Cochrane Consumer Network, London, UK.

Catherine Hofstetter (C)

OMERACT Patient Research Partner, Toronto, ON, Canada.

Olalekan Lee Aiyegbusi (OL)

Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

Anna Berardi (A)

Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
IRCCS NEUROMED, Pozzilli, Isernia, Italy.

Julie Farmer (J)

Faculty of Dentistry, University of Toronto, Toronto, ON, Canada.

Kirstie L Haywood (KL)

Warwick Research in Nursing, Division of Health Sciences, Warwick Medical School, University of Warwick, Gibbet Hill, Coventry, UK.

Karolin R Krause (KR)

Cundill Centre for Child and Youth Depression, Centre for Addiction and Mental Health, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Sarah Markham (S)

Department of Biostatistics and Health Informatics, Institute of Psychiatry Psychology and Neuroscience (IoPPN), King's College London, London, UK.

Evan Mayo-Wilson (E)

Department of Epidemiology, UNC Gillings School of Global Public Health, 2101C McGavran-Greenberg Hall Chapel Hill, Chapel Hill, NC, 27599, USA.

Ava Mehdipour (A)

School of Rehabilitation Science, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.

Juanna Ricketts (J)

Patient Partner, Halifax, NS, Canada.

Peter Szatmari (P)

Cundill Centre for Child and Youth Depression, Centre for Addiction and Mental Health, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Zahi Touma (Z)

Division of Rheumatology, Department of Medicine, Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada.

David Moher (D)

Centre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.

Martin Offringa (M)

Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada. martin.offringa@sickkids.ca.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada. martin.offringa@sickkids.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH